Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 363

1.

A novel study for fluorescence patterns of the parathyroid glands during surgery using a fluorescence spectroscopy system.

Idogawa H, Sakashita T, Homma A.

Eur Arch Otorhinolaryngol. 2020 Feb 20. doi: 10.1007/s00405-020-05849-4. [Epub ahead of print]

PMID:
32078027
2.

A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck.

Enokida T, Ogawa T, Homma A, Okami K, Minami S, Nakanome A, Shimizu Y, Maki D, Ueda Y, Fujisawa T, Motegi A, Ohkoshi A, Taguchi J, Ebisumoto K, Nomura S, Okano S, Tahara M.

Cancer Med. 2020 Jan 13. doi: 10.1002/cam4.2852. [Epub ahead of print]

3.

Corrigendum: Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine.

da Costa-Rocha IA, Campi-Azevedo AC, Peruhype-Magalhães V, Coelho-Dos-Reis JG, Fradico JRB, Souza-Lopes T, Reis LR, Freire LC, Costa-Pereira C, Mambrini JVM, Maia MLS, de Lima SMB, de Noronha TG, Xavier JR, Camacho LAB, de Albuquerque EM, Farias RHG, de Castro TDM, Homma A, Romano APM, Domingues CM, Martins RM, Teixeira-Carvalho A, Martins-Filho OA.

Front Immunol. 2019 Oct 22;10:2433. doi: 10.3389/fimmu.2019.02433. eCollection 2019.

4.

Minimally invasive surgery for laryngopharyngeal cancer: Multicenter feasibility study of a combination strategy involving transoral surgery and real-time indocyanine green fluorescence-navigated sentinel node navigation surgery.

Araki K, Tomifuji M, Shiotani A, Hirano S, Yokoyama J, Tsukahara K, Homma A, Yoshimoto S, Hasegawa Y.

Head Neck. 2020 Feb;42(2):254-261. doi: 10.1002/hed.25993. Epub 2019 Oct 31.

PMID:
31670870
5.

Short-Lived Immunity After 17DD Yellow Fever Single Dose Indicates That Booster Vaccination May Be Required to Guarantee Protective Immunity in Children.

Campi-Azevedo AC, Reis LR, Peruhype-Magalhães V, Coelho-Dos-Reis JG, Antonelli LR, Fonseca CT, Costa-Pereira C, Souza-Fagundes EM, da Costa-Rocha IA, Mambrini JVM, Lemos JAC, Ribeiro JGL, Caldas IR, Camacho LAB, Maia MLS, de Noronha TG, de Lima SMB, Simões M, Freire MDS, Martins RM, Homma A, Tauil PL, Vasconcelos PFC, Romano APM, Domingues CM, Teixeira-Carvalho A, Martins-Filho OA.

Front Immunol. 2019 Sep 26;10:2192. doi: 10.3389/fimmu.2019.02192. eCollection 2019.

6.

Analyses of natural courses of Japanese patients with Alzheimer's disease using placebo data from placebo-controlled, randomized clinical trials: Japanese Study on the Estimation of Clinical course of Alzheimer's disease.

Watanabe M, Nakamura Y, Yoshiyama Y, Kagimura T, Kawaguchi H, Matsuzawa H, Tachibana Y, Nishimura K, Kubota N, Kobayashi M, Saito T, Tamura K, Sato T, Takahashi M; Japanese Society of Scaling Keys of Evaluation Techniques for CNS Disorders Heterogeneity (SKETCH) study group, Homma A.

Alzheimers Dement (N Y). 2019 Aug 29;5:398-408. doi: 10.1016/j.trci.2019.07.004. eCollection 2019.

7.

Make-Up Therapy for Patients With Facial Nerve Palsy.

Fujiwara K, Furuta Y, Aoki W, Nakamaru Y, Morita S, Hoshino K, Fukuda A, Homma A.

Ann Otol Rhinol Laryngol. 2019 Aug;128(8):721-727. doi: 10.1177/0003489419841396.

PMID:
31307215
8.

17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, Brazil.

Campi-Azevedo AC, Peruhype-Magalhāes V, Coelho-Dos-Reis JG, Antonelli LR, Costa-Pereira C, Speziali E, Reis LR, Lemos JA, Ribeiro JGL, Bastos Camacho LA, de Sousa Maia ML, Barbosa de Lima SM, Simões M, de Menezes Martins R, Homma A, Cota Malaquias LC, Tauil PL, Costa Vasconcelos PF, Martins Romano AP, Domingues CM, Teixeira-Carvalho A, Martins-Filho OA; Collaborative Group for Studies of Yellow Fever Vaccine.

Emerg Infect Dis. 2019 Aug;25(8):1511-1521. doi: 10.3201/eid2508.181432. Epub 2019 Aug 17.

9.

Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine.

da Costa-Rocha IA, Campi-Azevedo AC, Peruhype-Magalhães V, Coelho-Dos-Reis JG, Fradico JRB, Souza-Lopes T, Reis LR, Freire LC, Costa-Pereira C, Mambrini JVM, Maia MLS, de Lima SMB, de Noronha TG, Xavier JR, Camacho LAB, de Albuquerque EM, Farias RHG, de Castro TDM, Homma A, Romano APM, Domingues CM, Martins RM, Teixeira-Carvalho A, Martins-Filho OA.

Front Immunol. 2019 Jun 21;10:1211. doi: 10.3389/fimmu.2019.01211. eCollection 2019. Erratum in: Front Immunol. 2019 Oct 22;10:2433.

10.

Differentiation Between Eosinophilic Otitis Media and Otitis Media Associated With Eosinophilic Granulomatosis With Polyangiitis.

Fukuda A, Morita S, Nakamaru Y, Hoshino K, Fujiwara K, Homma A.

Otol Neurotol. 2019 Sep;40(8):e796-e802. doi: 10.1097/MAO.0000000000002295.

PMID:
31290803
11.

Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines.

Hernandez N, Bucciol G, Moens L, Le Pen J, Shahrooei M, Goudouris E, Shirkani A, Changi-Ashtiani M, Rokni-Zadeh H, Sayar EH, Reisli I, Lefevre-Utile A, Zijlmans D, Jurado A, Pholien R, Drutman S, Belkaya S, Cobat A, Boudewijns R, Jochmans D, Neyts J, Seeleuthner Y, Lorenzo-Diaz L, Enemchukwu C, Tietjen I, Hoffmann HH, Momenilandi M, Pöyhönen L, Siqueira MM, de Lima SMB, de Souza Matos DC, Homma A, Maia MLS, da Costa Barros TA, de Oliveira PMN, Mesquita EC, Gijsbers R, Zhang SY, Seligman SJ, Abel L, Hertzog P, Marr N, Martins RM, Meyts I, Zhang Q, MacDonald MR, Rice CM, Casanova JL, Jouanguy E, Bossuyt X.

J Exp Med. 2019 Sep 2;216(9):2057-2070. doi: 10.1084/jem.20182295. Epub 2019 Jul 3.

PMID:
31270247
12.

Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial.

Burtness B, Haddad R, Dinis J, Trigo J, Yokota T, de Souza Viana L, Romanov I, Vermorken J, Bourhis J, Tahara M, Martins Segalla JG, Psyrri A, Vasilevskaya I, Nangia CS, Chaves-Conde M, Kiyota N, Homma A, Holeckova P, Del Campo JM, Asarawala N, Nicolau UR, Rauch D, Even C, Wang B, Gibson N, Ehrnrooth E, Harrington K, Cohen EEW; LUX-Head & Neck 2 investigators.

JAMA Oncol. 2019 Jun 13. doi: 10.1001/jamaoncol.2019.1146. [Epub ahead of print]

PMID:
31194247
13.

A review of head and neck cancer staging system in the TNM classification of malignant tumors (eighth edition).

Head and Neck Cancer Study Group (HNCSG), Monden N, Asakage T, Kiyota N, Homma A, Matsuura K, Hanai N, Kodaira T, Zenda S, Fujii H, Tahara M, Yokota T, Akimoto T, Iwae S, Onitsuka T, Ogawa T, Okano S, Takahashi S, Shimizu Y, Yonezawa K, Hayashi R.

Jpn J Clin Oncol. 2019 Jul 1;49(7):589-595. doi: 10.1093/jjco/hyz052. Review.

PMID:
31194232
14.

Machine-Learning-Based Prediction of Treatment Outcomes Using MR Imaging-Derived Quantitative Tumor Information in Patients with Sinonasal Squamous Cell Carcinomas: A Preliminary Study.

Fujima N, Shimizu Y, Yoshida D, Kano S, Mizumachi T, Homma A, Yasuda K, Onimaru R, Sakai O, Kudo K, Shirato H.

Cancers (Basel). 2019 Jun 10;11(6). pii: E800. doi: 10.3390/cancers11060800.

15.

[A Nutritional Supplement with a High Blend Ratio of ω-3 Fatty Acids(Prosure®) Reduces Severe Oral Mucositis and Body Weight Loss for Head and Neck Cancer Patients Treated with Chemoradiotherapy].

Mizumachi T, Kano S, Homma A, Akazawa M, Hasegawa C, Shiroishi Y, Okamoto C, Kumagai S, Nishimura M, Takasaki H, Takeda H, Yasuda K, Minatogawa H, Dekura Y, Onimaru R, Shirato H, Fukuda S.

Gan To Kagaku Ryoho. 2019 Apr;46(4):685-689. Japanese.

PMID:
31164507
16.

Desmoplastic small round cell tumor of the parotid gland-report of a rare case and a review of the literature.

Hatanaka KC, Takakuwa E, Hatanaka Y, Suzuki A, IIzuka S, Tsushima N, Mitsuhashi T, Sugita S, Homma A, Morinaga S, Hashegawa T, Matsuno Y.

Diagn Pathol. 2019 May 18;14(1):43. doi: 10.1186/s13000-019-0825-1. Review.

17.

Short-Term Hearing Prognosis of Ossiculoplasty in Pars Flaccida Cholesteatoma Using the EAONO/JOS Staging System.

Fukuda A, Morita S, Nakamaru Y, Hoshino K, Fujiwara K, Homma A.

J Int Adv Otol. 2019 Apr;15(1):2-7. doi: 10.5152/iao.2019.5983.

18.

Detection of post-vaccination enhanced dengue virus infection in macaques: An improved model for early assessment of dengue vaccines.

Borges MB, Marchevsky RS, Carvalho Pereira R, da Silva Mendes Y, Almeida Mendes LG, Diniz-Mendes L, Cruz MA, Tahmaoui O, Baudart S, Freire M, Homma A, Schneider-Ohrum K, Vaughn DW, Vanloubbeeck Y, Lorin C, Malice MP, Caride E, Warter L.

PLoS Pathog. 2019 Apr 22;15(4):e1007721. doi: 10.1371/journal.ppat.1007721. eCollection 2019 Apr.

19.

The utility of MRI histogram and texture analysis for the prediction of histological diagnosis in head and neck malignancies.

Fujima N, Homma A, Harada T, Shimizu Y, Tha KK, Kano S, Mizumachi T, Li R, Kudo K, Shirato H.

Cancer Imaging. 2019 Feb 4;19(1):5. doi: 10.1186/s40644-019-0193-9.

20.

Controversies in relation to neck management in N0 early oral tongue cancer.

Hanai N, Asakage T, Kiyota N, Homma A, Hayashi R.

Jpn J Clin Oncol. 2019 Apr 1;49(4):297-305. doi: 10.1093/jjco/hyy196. Review.

PMID:
30668761
21.

Safety and efficacy of concurrent carboplatin or cetuximab plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.

Hamauchi S, Yokota T, Mizumachi T, Onozawa Y, Ogawa H, Onoe T, Kamijo T, Iida Y, Nishimura T, Onitsuka T, Yasui H, Homma A.

Int J Clin Oncol. 2019 May;24(5):468-475. doi: 10.1007/s10147-018-01392-9. Epub 2019 Jan 17.

22.

The Diagnostic and Clinical Utility of the Myeloperoxidase-DNA Complex as a Biomarker in Otitis Media With Antineutrophil Cytoplasmic Antibody-associated Vasculitis.

Morita S, Nakamaru Y, Nakazawa D, Suzuki M, Hoshino K, Fukuda A, Hattanda F, Kusunoki K, Tomaru U, Ishizu A, Homma A.

Otol Neurotol. 2019 Feb;40(2):e99-e106. doi: 10.1097/MAO.0000000000002081.

PMID:
30570611
23.

Yellow fever outbreak in Brazil: the puzzle of rapid viral spread and challenges for immunisation.

Possas C, Lourenço-de-Oliveira R, Tauil PL, Pinheiro FP, Pissinatti A, Cunha RVD, Freire M, Martins RM, Homma A.

Mem Inst Oswaldo Cruz. 2018 Sep 3;113(10):e180278. doi: 10.1590/0074-02760180278. Review.

24.

Loss of TRIM29 Alters Keratin Distribution to Promote Cell Invasion in Squamous Cell Carcinoma.

Yanagi T, Watanabe M, Hata H, Kitamura S, Imafuku K, Yanagi H, Homma A, Wang L, Takahashi H, Shimizu H, Hatakeyama S.

Cancer Res. 2018 Dec 15;78(24):6795-6806. doi: 10.1158/0008-5472.CAN-18-1495. Epub 2018 Nov 2.

25.

Evaluation of Vertical Semicircular Canal Function in Patients With Vestibular Schwannoma.

Fujiwara K, Yanagi H, Morita S, Hoshino K, Fukuda A, Nakamaru Y, Homma A.

Ann Otol Rhinol Laryngol. 2019 Feb;128(2):113-120. doi: 10.1177/0003489418808545. Epub 2018 Oct 26.

PMID:
30360640
26.

Randomized phase III study to evaluate the value of omission of prophylactic neck dissection for stage I/II tongue cancer: Japan Clinical Oncology Group study (JCOG1601, RESPOND).

Tanaka K, Hanai N, Eba J, Mizusawa J, Asakage T, Homma A, Kiyota N, Fukuda H, Hayashi R; Head and Neck Cancer Study Group of the Japan Clinical Oncology Group.

Jpn J Clin Oncol. 2018 Dec 1;48(12):1105-1108. doi: 10.1093/jjco/hyy125.

PMID:
30346569
27.

Semi-quantitative analysis of pre-treatment morphological and intratumoral characteristics using 18F-fluorodeoxyglucose positron-emission tomography as predictors of treatment outcome in nasal and paranasal squamous cell carcinoma.

Fujima N, Hirata K, Shiga T, Yasuda K, Onimaru R, Tsuchiya K, Kano S, Mizumachi T, Homma A, Kudo K, Shirato H.

Quant Imaging Med Surg. 2018 Sep;8(8):788-795. doi: 10.21037/qims.2018.09.09.

28.

Integrating quantitative morphological and intratumoural textural characteristics in FDG-PET for the prediction of prognosis in pharynx squamous cell carcinoma patients.

Fujima N, Hirata K, Shiga T, Li R, Yasuda K, Onimaru R, Tsuchiya K, Kano S, Mizumachi T, Homma A, Kudo K, Shirato H.

Clin Radiol. 2018 Dec;73(12):1059.e1-1059.e8. doi: 10.1016/j.crad.2018.08.011. Epub 2018 Sep 21.

29.

Early prediction of lenvatinib treatment efficacy by using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma that is refractory to radioiodine treatment: a protocol for a non-randomized single-arm multicenter observational study.

Takeuchi S, Shiga T, Hirata K, Taguchi J, Magota K, Ariga S, Gouda T, Ohhara Y, Homma R, Shimizu Y, Kinoshita I, Tsuji Y, Homma A, Iijima H, Tamaki N, Dosaka-Akita H.

BMJ Open. 2018 Aug 30;8(8):e021001. doi: 10.1136/bmjopen-2017-021001.

30.

Oncocytoma of the Parotid Gland with Facial Nerve Paralysis.

Hamada S, Fujiwara K, Hatakeyama H, Homma A.

Case Rep Otolaryngol. 2018 Jun 21;2018:7687951. doi: 10.1155/2018/7687951. eCollection 2018.

31.

Sanger-based sequencing technology for yellow fever vaccine genetic quality control.

Pestana CP, Lawson-Ferreira R, Lessa-Aquino C, Leal MDLF, Freire MDS, Homma A, Medeiros MA.

J Virol Methods. 2018 Oct;260:82-87. doi: 10.1016/j.jviromet.2018.07.006. Epub 2018 Jul 26.

PMID:
30009851
32.

Intra-arterial Chemoradiation Therapy as an Option for Maxillary Sinus Cancers.

Homma A, Onimaru R.

Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):763. doi: 10.1016/j.ijrobp.2018.03.051. Epub 2018 Jun 20. No abstract available.

PMID:
29976485
33.

Comparison of the University of Pittsburgh staging system and the eighth edition of the American Joint Committee on Cancer TNM classification for the prognostic evaluation of external auditory canal cancer.

Morita S, Mizumachi T, Nakamaru Y, Sakashita T, Kano S, Hoshino K, Fukuda A, Fujiwara K, Homma A.

Int J Clin Oncol. 2018 Dec;23(6):1029-1037. doi: 10.1007/s10147-018-1314-3. Epub 2018 Jul 5.

34.

HIV cure: global overview of bNAbs' patents and related scientific publications.

Possas C, Antunes AMS, Lins Mendes FM, Veloso V, Martins RM, Homma A.

Expert Opin Ther Pat. 2018 Jul;28(7):551-560. doi: 10.1080/13543776.2018.1495708. Review.

PMID:
29962249
35.

Multi-parameter approach to evaluate the timing of memory status after 17DD-YF primary vaccination.

Costa-Pereira C, Campi-Azevedo AC, Coelho-Dos-Reis JG, Peruhype-Magalhães V, Araújo MSS, do Vale Antonelli LR, Fonseca CT, Lemos JA, Malaquias LCC, de Souza Gomes M, Rodrigues Amaral L, Rios M, Chancey C, Persi HR, Pereira JM, de Sousa Maia ML, Freire MDS, Martins RM, Homma A, Simões M, Yamamura AY, Farias RHG, Romano APM, Domingues CM, Tauil PL, Vasconcelos PFC, Caldas IR, Camacho LA, Teixeira-Carvalho A, Martins-Filho OA.

PLoS Negl Trop Dis. 2018 Jun 7;12(6):e0006462. doi: 10.1371/journal.pntd.0006462. eCollection 2018 Jun.

36.

Duration of post-vaccination immunity to yellow fever in volunteers eight years after a dose-response study.

de Menezes Martins R, Maia MLS, de Lima SMB, de Noronha TG, Xavier JR, Camacho LAB, de Albuquerque EM, Farias RHG, da Matta de Castro T, Homma A; Collaborative Group for Studies on Duration of Immunity from Yellow Fever Vaccine.

Vaccine. 2018 Jun 27;36(28):4112-4117. doi: 10.1016/j.vaccine.2018.05.041. Epub 2018 May 18.

37.

Genetic mutation analysis of the malignant transformation of sinonasal inverted papilloma by targeted amplicon sequencing.

Yasukawa S, Kano S, Hatakeyama H, Nakamaru Y, Takagi D, Mizumachi T, Suzuki M, Suzuki T, Nakazono A, Tanaka S, Nishihara H, Homma A.

Int J Clin Oncol. 2018 Oct;23(5):835-843. doi: 10.1007/s10147-018-1296-1. Epub 2018 May 19.

38.

Sirtuin-1 Controls Poly (I:C)-Dependent Matrix Metalloproteinase 9 Activation in Primary Human Nasal Epithelial Cells.

Suzuki M, Ramezanpour M, Cooksley C, Li J, Nakamaru Y, Homma A, Psaltis A, Wormald PJ, Vreugde S.

Am J Respir Cell Mol Biol. 2018 Oct;59(4):500-510. doi: 10.1165/rcmb.2017-0415OC.

PMID:
29767533
39.

Characterization of recent and minimally passaged Brazilian dengue viruses inducing robust infection in rhesus macaques.

Borges MB, Marchevsky RS, Mendes YS, Mendes LG, Duarte AC, Cruz M, de Filippis AMB, Vasconcelos PFC, Freire M, Homma A, Mossman S, Lepine E, Vanloubbeeck Y, Lorin C, Malice MP, Caride E, Warter L.

PLoS One. 2018 Apr 25;13(4):e0196311. doi: 10.1371/journal.pone.0196311. eCollection 2018.

40.

Validation of the 8th edition of the AJCC/UICC TNM staging system for tongue squamous cell carcinoma.

Kano S, Sakashita T, Tsushima N, Mizumachi T, Nakazono A, Suzuki T, Yasukawa S, Homma A.

Int J Clin Oncol. 2018 Oct;23(5):844-850. doi: 10.1007/s10147-018-1276-5. Epub 2018 Apr 19.

41.

The surgical outcome of minimally invasive pharyngo-laryngo-oesophagectomy in prone position.

Ogino M, Ebihara Y, Homma A, Tanaka K, Nakanishi Y, Asano T, Noji T, Kurashima Y, Murakami S, Nakamura T, Tsuchikawa T, Okamura K, Shichinohe T, Hirano S.

J Minim Access Surg. 2018 Mar 23. doi: 10.4103/jmas.JMAS_230_17. [Epub ahead of print]

42.

Rapid detection of superficial head and neck squamous cell carcinoma by topically spraying fluorescent probe targeting dipeptidyl peptidase-IV.

Mizushima T, Ohnishi S, Shimizu Y, Hatanaka Y, Hatanaka KC, Kuriki Y, Kamiya M, Homma A, Yamamoto K, Ono S, Urano Y, Sakamoto N.

Head Neck. 2018 Jul;40(7):1466-1475. doi: 10.1002/hed.25126. Epub 2018 Mar 6.

PMID:
29509281
43.

Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02).

Tahara M, Kiyota N, Yokota T, Hasegawa Y, Muro K, Takahashi S, Onoe T, Homma A, Taguchi J, Suzuki M, Minato K, Yane K, Ueda S, Hara H, Saijo K, Yamanaka T.

Ann Oncol. 2018 Apr 1;29(4):1004-1009. doi: 10.1093/annonc/mdy040.

44.

Elevated Level of Myeloperoxidase-Deoxyribonucleic Acid Complex in the Middle Ear Fluid Obtained From Patients With Otitis Media Associated With Antineutrophil Cytoplasmic Antibody-associated Vasculitis.

Morita S, Nakamaru Y, Nakazawa D, Hattanda F, Shida H, Kusunoki Y, Watanabe K, Masuda S, Takagi D, Suzuki M, Hoshino K, Fukuda A, Tomaru U, Homma A, Ishizu A.

Otol Neurotol. 2018 Apr;39(4):e257-e262. doi: 10.1097/MAO.0000000000001708.

PMID:
29342044
45.

Anti-mumps IgM antibody positive rate with sudden sensorineural hearing loss using second-generation enzyme immunoassay: A retrospective, multi-institutional investigation in Hokkaido, Japan.

Fukuda A, Morita S, Nakamaru Y, Hoshino K, Fujiwara K, Akazawa S, Sakashita T, Obara N, Homma A.

Auris Nasus Larynx. 2018 Oct;45(5):911-915. doi: 10.1016/j.anl.2017.11.016. Epub 2017 Dec 8.

46.

Clinical Characteristics and Treatment Outcomes for Patients With External Auditory Canal Cholesteatoma.

Morita S, Nakamaru Y, Fukuda A, Fujiwara K, Hoshino K, Homma A.

Otol Neurotol. 2018 Feb;39(2):189-195. doi: 10.1097/MAO.0000000000001659.

PMID:
29210949
47.

Urgent call for action: avoiding spread and re-urbanisation of yellow fever in Brazil.

Possas C, Martins RM, Oliveira RL, Homma A.

Mem Inst Oswaldo Cruz. 2018 Jan;113(1):1-2. doi: 10.1590/0074-02760170361. No abstract available.

48.

Easy Screening for Mild Alzheimer's Disease and Mild Cognitive Impairment from Elderly Speech.

Kato S, Homma A, Sakuma T.

Curr Alzheimer Res. 2018;15(2):104-110. doi: 10.2174/1567205014666171120144343.

PMID:
29165082
49.

Dose-finding and efficacy confirmation trial of the superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for locally advanced maxillary sinus cancer (Japan Clinical Oncology Group 1212): Dose-finding phase.

Homma A, Onimaru R, Matsuura K, Shinomiya H, Sakashita T, Shiga K, Tachibana H, Nakamura K, Mizusawa J, Kitahara H, Eba J, Fukuda H, Fujii M, Hayashi R.

Head Neck. 2018 Mar;40(3):475-484. doi: 10.1002/hed.25001. Epub 2017 Nov 11.

50.

Value of T1-weighted Magnetic Resonance Imaging in Cholesteatoma Detection.

Fukuda A, Morita S, Harada T, Fujiwara K, Hoshino K, Nakamaru Y, Homma A.

Otol Neurotol. 2017 Dec;38(10):1440-1444. doi: 10.1097/MAO.0000000000001558.

PMID:
29084089

Supplemental Content

Support Center